Norman Swan
speaker
15,786 appearances
142 recordings
2 series
first heard Jul 2005
last heard 5d ago
Norman Swan’s voice in public audio — every appearance, attributed to the second.
Trend
recordings per month · last 12 monthsRecordings per month over the last 12 months — 23 in all, peaking in Jun 2026 with 7.
Appearances
It's caused significant anxiety and distress for patients.
matched
We've covered that story and how patients can continue to access it.
matched
And Norman spoke with AstraZeneca, the company who manages Zoladex.
matched
Yeah, that's right.
matched
Americans
matched
On ABC Radio National, you're with The Health
matched
So we've got a few things in the mailbag, Lauren.
matched
And the first one, just to give context for everybody, is in relation to a story that Norman and I did last week on the Horizon trial, which was meant to be this absolutely blockbuster drug for lipoprotein, little a, that specific cholesterol that's genetically determined.
matched
And the Novartis results had come out and didn't look so good.
matched
So we spoke to a cardiologist about the trial and we've had an email from Sue.
matched
Sue writes, your
matched
That will be very interesting.
matched
And I have to say, the study that we covered last week, the Novartis one, was a drug called pelicasin.
matched
And this one is different.
matched
It's lepidiserin is the drug, but they're both obviously targeting the same pathway in terms of lowering the lipoprotein delay.
matched
The question is, and this is what we...
matched
explored on the show last week is clearly these drugs appear to lower the lipoprotein delay.
matched
In the Novartis or the Horizon trial, there was no impact on dying from heart disease or cardiovascular outcomes.
matched
Fingers and toes crossed, I think.
matched
It's very exciting that you're on the trial.
matched
Showing 181–200 of 15,786 · page 10 of 790
← Previous
Next →